Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: A role for osteocytes in particle-induced inflammation

Bone

Volumn 45, Issue 3, 2009, Pages 528-533

  Kanaji, Arihiko ^a   Caicedo, Marco S ^a   Virdi, Amarjit S ^a   Sumner, D Rick ^a   Hallab, Nadim J ^a   Sena, Kotaro ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

MLO Y4 cell; Osteocyte apoptosis; Osteolysis; Tumor necrosis factor ; Wear debris

Indexed keywords

ALLOY; CASPASE 3; CASPASE 7; CHROMIUM; COBALT; INTERLEUKIN 6; MOLYBDENUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; INFLAMMATION; MOUSE; NONHUMAN; OSTEOCYTE; OSTEOLYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; APOPTOSIS; BONE RESORPTION; CELL LINE; INFLAMMATION; INTERLEUKIN-6; MICE; OSTEOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VITALLIUM;

EID: 67949120307     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.05.020     Document Type: Article

References (44)

1. Ahuja S.S., Zhao S., Bellido T., Plotkin L.I., Jimenez F., and Bonewald L.F. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144 (2003) 1761-1769
2. Bonewald L.F. Osteocytes as dynamic multifunctional cells. Ann. N.Y. Acad. Sci. 1116 (2007) 281-290
3. Busse B., Hahn M., Niecke M., Jobke B., Puschel K., Delling G., et al. Allocation of nonbirefringent wear debris: darkfield illumination associated with PIXE microanalysis reveals cobalt deposition in mineralized bone matrix adjacent to CoCr implants. J. Biomed. Mater. Res. A 87 (2008) 536-545
4. Caicedo M.S., Desai R., McAllister K., Reddy A., Jacobs J.J., and Hallab N.J. Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity. J. Orthop. Res. 27 (2008) 847-854
5. Cardoso L., Herman B.C., Verborgt O., Laudier D., Majeska R.J., and Schaffler M.B. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J. Bone Miner. Res. 24 (2009) 597-605
6. Chenoufi H.L., Diamant M., Rieneck K., Lund B., Stein G.S., and Lian J.B. Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone. J. Cell Biochem. 81 (2001) 666-678
7. Childs L.M., Goater J.J., O'Keefe R.J., and Schwarz E.M. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J. Bone Joint Surg. Am. 83-A (2001) 1789-1797
8. Childs L.M., Goater J.J., O'Keefe R.J., and Schwarz E.M. Efficacy of etanercept for wear debris-induced osteolysis. J. Bone Miner. Res. 16 (2001) 338-347
9. Chung E.H., Gilbert M., Virdi A.S., Sena K., Sumner D.R., and Healy K.E. Biomimetic artificial ECMs stimulate bone regeneration. J. Biomed. Mater. Res. A 79 (2006) 815-826
10. Crawford R.W., and Murray D.W. Total hip replacement: indications for surgery and risk factors for failure. Ann. Rheum. Dis. 56 (1997) 455-457
11. Doodes P.D., Cao Y., Hamel K.M., Wang Y., Farkas B., Iwakura Y., et al. Development of proteoglycan-induced arthritis is independent of IL-17. J. Immunol. 181 (2008) 329-337
12. Goodman S.B., Huie P., Song Y., Schurman D., Maloney W., Woolson S., et al. Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J. Bone Joint Surg. Br. 80 (1998) 531-539
13. Greenfield E.M., and Bechtold J. What other biologic and mechanical factors might contribute to osteolysis?. J. Am. Acad. Orthop. Surg. 16 Suppl. 1 (2008) S56-S62
14. Hicks D.G., Judkins A.R., Sickel J.Z., Rosier R.N., Puzas J.E., and O'Keefe R.J. Granular histiocytosis of pelvic lymph nodes following total hip arthroplasty. The presence of wear debris, cytokine production, and immunologically activated macrophages. J. Bone Joint Surg. Am. 78 (1996) 482-496
15. Holt G., Murnaghan C., Reilly J., and Meek R.M. The biology of aseptic osteolysis. Clin. Orthop. Relat. Res. 460 (2007) 240-252
16. Jacobs J.J., Campbell P.A., and Konttinen T. How has the biologic reaction to wear particles changed with newer bearing surfaces?. J. Am. Acad. Orthop. Surg. 16 Suppl. 1 (2008) S49-S55
17. Jacobs J.J., Hallab N.J., Urban R.M., and Wimmer M.A. Wear particles. J. Bone Joint Surg. Am. 88 Suppl. 2 (2006) 99-102
18. Kato Y., Windle J.J., Koop B.A., Mundy G.R., and Bonewald L.F. Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Miner. Res. 12 (1997) 2014-2023
19. Kobayashi Y., Kim K.J., and Itoh T. Gene expression of bone-resorbing cytokines in rat osteolysis model. J. Orthop. Sci. 10 (2005) 62-69
20. Konttinen Y.T., Xu J.W., Waris E., Li T.F., Gomez-Barrena E., Nordsletten L., et al. Interleukin-6 in aseptic loosening of total hip replacement prostheses. Clin. Exp. Rheumatol. 20 (2002) 485-490
21. Kurtz S., Ong K., Lau E., Mowat F., and Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89 (2007) 780-785
22. Kurtz S., Ong K., Lau E., Mowat F., and Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89 (2007) 780-785
23. Kurtz S.M., Ong K.L., Schmier J., Mowat F., Saleh K., Dybvik E., et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J. Bone Joint Surg. Am. 89 Suppl. 3 (2007) 144-151
24. Lohmann C.H., Dean D.D., Bonewald L.F., Schwartz Z., and Boyan B.D. Nitric oxide and prostaglandin E2 production in response to ultra-high molecular weight polyethylene particles depends on osteoblast maturation state. J. Bone Joint Surg. Am. 84-A (2002) 411-419
25. Merkel K.D., Erdmann J.M., McHugh K.P., Abu-Amer Y., Ross F.P., and Teitelbaum S.L. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am. J. Pathol. 154 (1999) 203-210
26. Noble B.S. The osteocyte lineage. Arch. Biochem. Biophys. 473 (2008) 106-111
27. Ragab A.A., Nalepka J.L., Bi Y., and Greenfield E.M. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am. J. Physiol. Cell Physiol. 283 (2002) C679-C687
28. Schwarz E.M., Lu A.P., Goater J.J., Benz E.B., Kollias G., Rosier R.N., et al. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J. Orthop. Res. 18 (2000) 472-480
29. Sena K., Leven R.M., Mazhar K., Sumner D.R., and Virdi A.S. Early gene response to low-intensity pulsed ultrasound in rat osteoblastic cells. Ultrasound Med. Biol. 31 (2005) 703-708
30. Sena K., Sumner D.R., and Virdi A.S. Modulation of VEGF expression in rat bone marrow stromal cells by GDF-5. Connect Tissue Res. 48 (2007) 324-331
31. Stea S., Visentin M., Granchi D., Ciapetti G., Donati M.E., Sudanese A., et al. Cytokines and osteolysis around total hip prostheses. Cytokine 12 (2000) 1575-1579
32. Steflik D.E., Corpe R.S., Lake F.T., Young T.R., Sisk A.L., Parr G.R., et al. Ultrastructural analyses of the attachment (bonding) zone between bone and implanted biomaterials. J. Biomed. Mater. Res. 39 (1998) 611-620
33. Taki N., Tatro J.M., Lowe R., Goldberg V.M., and Greenfield E.M. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone 40 (2007) 1276-1283
34. Tan S.D., Kuijpers-Jagtman A.M., Semeins C.M., Bronckers A.L., Maltha J.C., Von den Hoff J.W., et al. Fluid shear stress inhibits TNFalpha-induced osteocyte apoptosis. J. Dent. Res. 85 (2006) 905-909
35. Tatsumi S., Ishii K., Amizuka N., Li M., Kobayashi T., Kohno K., et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5 (2007) 464-475
36. Tomkinson A., Gevers E.F., Wit J.M., Reeve J., and Noble B.S. The role of estrogen in the control of rat osteocyte apoptosis. J. Bone Miner. Res. 13 (1998) 1243-1250
37. Tuan R.S., Lee F.Y., Konttinen T., Wilkinson J.M., and Smith R.L. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?. J. Am. Acad. Orthop. Surg. 16 Suppl. 1 (2008) S42-S48
38. Udagawa N., Takahashi N., Katagiri T., Tamura T., Wada S., Findlay D.M., et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182 (1995) 1461-1468
39. Verborgt O., Gibson G.J., and Schaffler M.B. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J. Bone Miner. Res. 15 (2000) 60-67
40. Vermes C., Chandrasekaran R., Jacobs J.J., Galante J.O., Roebuck K.A., and Glant T.T. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J. Bone Joint Surg. Am. 83-A (2001) 201-211
41. Wilkinson J.M., Wilson A.G., Stockley I., Scott I.R., Macdonald D.A., Hamer A.J., et al. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J. Bone Miner. Res. 18 (2003) 1995-2001
42. Wong P.K., Quinn J.M., Sims N.A., van Nieuwenhuijze A., Campbell I.K., and Wicks I.P. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum. 54 (2006) 158-168
43. Xu J.W., Konttinen Y.T., Lassus J., Natah S., Ceponis A., Solovieva S., et al. Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR). Clin. Exp. Rheumatol. 14 (1996) 643-648
44. Yang W., Harris M.A., Heinrich J.G., Guo D., Bonewald L.F., and Harris S.E. Gene expression signatures of a fibroblastoid preosteoblast and cuboidal osteoblast cell model compared to the MLO-Y4 osteocyte cell model. Bone 44 (2009) 32-45